GAL and neoplasm: Initial studies on the ability of α-gal epitopes to enhance immunogenicity of tumor cells were performed in anti-Gal–producing GT-KO mice, using the highly tumorigenic B16 melanoma mouse cells which lack the α-gal epitope, as a tumor model (LaTemple et al., 1999).